NUTRAPLUS INDIA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.1 INR | +5.00% |
|
-.--% | -.--% |
| 05-26 | Nutraplus India Limited Reports Earnings Results for the Full Year Ended March 31, 2022 | CI |
| 2020 | Nutraplus India Limited Announces Shifting of Registered Office | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 7.18M 86.18K 6.73M | Sales 2023 | - | Capitalization | 71.59M 859K 67.06M |
|---|---|---|---|---|---|
| Net income 2022 | -30M -360K -28.1M | Net income 2023 | -1M -12K -937K | EV / Sales 2022 | 12.1 x |
| Net Debt 2022 | 15.36M 184K 14.39M | Net Debt 2023 | 15.6M 187K 14.62M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-2.36
x | P/E ratio 2023 |
-42
x | Employees | 9 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.74% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.00% |
3 years
1.82
2.78
5 years
1.8216.60
10 years
1.82224.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 14/03/02 | |
| Chairman | 70 | 05/02/90 | |
Louis Rumao
ADM | Chief Administrative Officer | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 05/02/90 | |
| Chief Executive Officer | 40 | 14/03/02 | |
| Director/Board Member | 64 | 23/06/16 |
Nutraplus India Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (APIs). The Company's main products include drugs and pharmaceuticals.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 857K | |
| +42.69% | 750B | |
| +34.11% | 606B | |
| -6.87% | 356B | |
| +18.74% | 326B | |
| +6.76% | 286B | |
| +18.08% | 246B | |
| -3.44% | 213B | |
| +11.35% | 213B | |
| +2.64% | 167B |
- Stock Market
- Equities
- NUTRA6 Stock
